BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1374974)

  • 1. Further practical experiences in the recognition and management of carcinoma in situ of the testis.
    Mumperow E; Lauke H; Holstein AF; Hartmann M
    Urol Int; 1992; 48(2):162-6. PubMed ID: 1374974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
    Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
    Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
    Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
    Oliver RT; Ong J; Berney D; Nargund V; Badenoch D; Shamash J
    APMIS; 2003 Jan; 111(1):86-91; discussion 91-2. PubMed ID: 12752243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
    von der Maase H
    Acta Oncol; 2005; 44(6):523-5. PubMed ID: 16165909
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
    Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
    Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. N. E. Skakkebaek. Histopathology 1978; 2; 157-170.
    Skakkebaek NE
    Histopathology; 2002 Sep; 41(3A):2-3; discussion 3-4. PubMed ID: 12405921
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
    Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
    Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early detection of a contralateral second carcinoma in patients with testicular tumors caused by testicular carcinoma in situ].
    Kleinschmidt K; Weissbach L; Holstein AF
    Urologe A; 1989 Sep; 28(5):281-4. PubMed ID: 2573191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoma in situ of the testis].
    Culine S; Terrier-Lacombe MJ; Kattan J; Droz JP
    Bull Cancer; 1994 Apr; 81(4):318-25. PubMed ID: 7703549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for carcinoma in situ testis.
    Mortensen MS; Gundgaard MG; Daugaard G
    Int J Androl; 2011 Aug; 34(4 Pt 2):e32-6. PubMed ID: 21651575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the testis: biology, screening and management.
    Giwercman A; Skakkebaek NE
    Eur Urol; 1993; 23 Suppl 2():19-21. PubMed ID: 8390358
    [No Abstract]   [Full Text] [Related]  

  • 13. [Germ cell tumors of the testes: state of the art].
    Fléchon A; Droz JP
    Cancer Radiother; 2000; 4(1):27-31. PubMed ID: 10742806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.
    von der Maase H; Rørth M; Walbom-Jørgensen S; Sørensen BL; Christophersen IS; Hald T; Jacobsen GK; Berthelsen JG; Skakkebaek NE
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1398-401. PubMed ID: 3026550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
    Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
    J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemotherapy on carcinoma in situ of the testis.
    Christensen TB; Daugaard G; Geertsen PF; von der Maase H
    Ann Oncol; 1998 Jun; 9(6):657-60. PubMed ID: 9681081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metachronous testicular tumor of an extragonadal germ cell tumor].
    Häcker A; Hatzinger M; Knoll T; Michel MS; Köhrmann KU; Alken P; Siegsmund M
    Aktuelle Urol; 2003 Oct; 34(6):413-5. PubMed ID: 14579191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts of radiation treatment of carcinoma in situ of the testis.
    Giwercman A; von der Maase H; Rørth M; Skakkebaek NE
    World J Urol; 1994; 12(3):125-30. PubMed ID: 7951337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.